Jaguar Health (JAGX) Revenue (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Revenue data on file, last reported at $20.3 million in Q1 2026.

• Revenue for Q1 2026 came in at $20.3 million, up 815.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.6 million (up 155.96% YoY), and the FY2025 annual result was $11.5 million, down 1.52% from the prior year.
• Revenue rose to $20.3 million in Q1 2026 per JAGX's latest filing, from $3.2 million in the prior quarter.
• Over five years, Revenue peaked at $20.3 million in Q1 2026 and troughed at $20000.0 in Q1 2022.
• A 5-year average of $3.4 million and a median of $2.8 million in 2023 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2023: Revenue slumped 98.5% in 2022, then soared 7087.5% in 2023.
• A 5-year view of Revenue shows it stood at $32000.0 in 2022, then soared by 7087.5% to $2.3 million in 2023, then jumped by 52.57% to $3.5 million in 2024, then declined by 7.81% to $3.2 million in 2025, then soared by 526.65% to $20.3 million in 2026.
• Business Quant data shows JAGX's Revenue at $20.3 million in Q1 2026, $3.2 million in Q4 2025, and $3.1 million in Q3 2025.